U.S. Oil and Gas Stock News

Wondering if Merck at around US$119 per share still offers value, or if most of the upside is already reflected in the price? This article walks through the key data points that matter for you. Merck’s share price sits near US$119.37, with returns of 4.3% over 7 days, a 3.6% decline over 30 days, 12.1% year to date and 40.4% over the past year. This raises fair questions about both growth potential and how risk is being priced in. Recent news coverage around Merck has focused on its position...

Regulators are preparing to ease bank capital requirements, reducing the amount of capital some banks may need to hold against their assets. Moody's has flagged these planned changes as credit negative, signaling concern about higher credit risk for financial institutions. The shift in regulatory stance could influence how Moody's assesses bank balance sheets and assigns credit ratings across the sector. Moody's, traded as NYSE:MCO, sits at the center of global credit assessment, so any...

If you are wondering whether Commerce Bancshares at around US$48.54 is starting to look like value, or still has more room to fall or recover, this article will walk you through what the current price might be implying. The stock has gained 2.2% over the last 7 days, although it remains 7.1% lower over the past month and 17.1% lower over the last year. This may have some investors reassessing both its potential and its risks. Recent attention on the broader US banking sector, shifts in...

If you are wondering whether MetLife's current share price reflects its underlying worth, the recent moves in the stock give you plenty to think about. The shares last closed at US$70.39, with a 2.6% gain over the past week, a 6.4% decline over 30 days, and returns of 12.4% decline year to date and 13.6% decline over the last year, set against gains of 36.7% and 34.8% over 3 and 5 years respectively. Recent headlines around MetLife have focused on the business as a large US insurer,...

Cadence Design Systems (NasdaqGS:CDNS) has appointed Dr. Alok Jain as Managing Director for India. The appointment positions India as a key innovation and R&D hub for the company’s semiconductor and design software efforts. Dr. Jain is expected to focus on relationships across government, academia, and industry within India’s growing chip ecosystem. Cadence Design Systems, a major player in electronic design automation and semiconductor IP, is putting more executive weight behind India as a...

Wondering if Moderna at US$53.54 is a bargain or a value trap? This article walks through what the numbers are really saying about the stock. The share price return sits at 2.2% over 7 days, 6.5% over 30 days, 73.5% year to date and 70.1% over the last year, alongside a 64.0% decline over 3 years and a 59.1% decline over 5 years. Recent headlines around Moderna have focused on its position in the pharmaceutical and biotech space and how investors are reassessing companies in this part of the...

Investor activism meets softer quarterly results AutoNation (AN) is facing closer investor scrutiny after a softer Q4, with revenue down 3.9% year on year and earnings missing analyst estimates, even as After-Sales and Customer Financial Services reported record gross profit. See our latest analysis for AutoNation. AutoNation's share price has softened recently, with a 30 day share price return of 1.64% decline and a 90 day share price return of 8.82% decline, even as the 1 year total...

Wondering if Oncolytics Biotech at around US$0.95 is offering value or just extra risk? This article breaks down what that price tag could really mean for you. The stock is roughly flat year to date with a 3.4% decline. It has returned 54.7% over the last year, which can raise questions about how much potential or risk might already be reflected in the price. Recent coverage has focused on Oncolytics Biotech's progress as a clinical stage cancer therapy developer and the implications of its...

Valero Energy (NYSE:VLO) is facing a worker lawsuit that alleges negligence after the recent explosion at its Port Arthur refinery. The suit claims gross negligence related to safety practices and working conditions at one of Valero's largest facilities. This legal action adds fresh scrutiny to the company's operational risk management and potential liability exposure. Valero is one of the largest independent refiners in the US, with operations that supply transportation fuels and other...

If you are wondering whether BioCryst Pharmaceuticals at US$9.40 still offers value, it helps to start by lining up the recent share performance with what the fundamentals suggest the stock might be worth. Over the short term, the share price return sits at 2.6% over 7 days, 24.0% over 30 days and 25.3% year to date, with a 20.5% return over 1 year and 9.8% over 3 years, compared with a 5 year return of a 7.6% decline. These moves are occurring as investors continue to respond to ongoing...

Over the last 7 days, the United States market has remained flat, yet it has risen by 16% over the past year with expectations of earnings growing annually by a similar rate in the coming years. In this context of steady growth, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and potential to outperform these promising market conditions.

In the last week, the United States market has stayed flat, although it is up 16% over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying stocks trading below their estimated intrinsic value can present opportunities for investors seeking potential growth at a reasonable price.

If you are wondering whether Pitney Bowes at around US$10.91 is still offering value or if the easy part of the move is behind it, the starting point is understanding how its current price lines up with different valuation checks. The stock has posted returns of 11.3% over the last 7 days, 5.1% over the past month, 5.6% year to date and 18.6% over the last year, while the 3 year return is very large and the 5 year return sits at 61.5%. Recent headlines have focused on Pitney Bowes in the...

If you are wondering whether Redwire's current share price lines up with its underlying worth, this article will walk you through what the numbers are actually saying. Redwire's share price closed at US$9.16 recently, with a 12.8% return over the last 30 days, a 1.4% return year to date, and a 17.1% decline over the past year, while the 3-year return sits at a very large gain. Recent coverage has focused on Redwire within the Aerospace and Defense space, with attention on how the business is...

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by 16%, with earnings forecasted to grow at a similar rate annually. In this context of steady growth, stocks with strong insider ownership can be particularly appealing as they often indicate confidence in a company's future prospects and alignment between management and shareholders.

Central Bancompany (CBC) has just been added to a wide range of Russell value and broad market indexes, an inclusion that often shifts how institutional investors and index funds look at the stock. See our latest analysis for Central Bancompany. At a share price of US$23.72, Central Bancompany has seen modest short term softness, with a 30 day share price return of a 2.43% decline. However, the 1 year total shareholder return of 73.02% and 5 year total shareholder return of 134.52% point to...

In the last week, the market has stayed flat, but over the past 12 months, it has risen by 16%, with earnings projected to grow annually at a similar rate. In light of these conditions, identifying stocks with solid fundamentals and growth potential is crucial for investors seeking opportunities. Penny stocks may be an outdated term, yet they represent a valuable investment area for those interested in smaller or newer companies that offer affordability and potential upside when backed by...

In the last week, the United States market has remained flat, though it has risen by 16% over the past year with earnings expected to grow annually at the same rate. In this environment, identifying stocks with strong fundamentals and growth potential can offer investors opportunities to uncover hidden treasures in a dynamic market landscape.

Over the last 7 days, the United States market has remained flat, yet it is up 16% over the past year with earnings forecasted to grow by 16% annually. In this environment, dividend stocks with yields of at least 3% can offer investors a combination of income and potential growth, making them an attractive consideration.

Context for Progress Software’s recent share performance Progress Software (PRGS) has drawn attention after a weak run in the stock, with the share price at US$27.33 and negative returns over the past month, past 3 months, year to date and over the past year. Against that backdrop, investors are weighing a business that reports US$977.83 million in revenue and US$73.13 million in net income, alongside a reported value score of 5 and indications of a sizable intrinsic discount. See our latest...

Earlier this year, Fidelity National Financial, Inc. announced that Jeffrey Heighton joined FNF Agency Operations as President of Enterprise Solutions – Agency, where he will work with title agents to enhance growth, financial performance, and operational scalability through technology, outsourcing, and disciplined business management. By expanding FNF’s consultative model and emphasizing technology-enabled execution across its agent network, Heighton’s appointment signals a deeper push to...

What stands out about Patria Investments right now Patria Investments (PAX) has drawn fresh attention after recent trading left the shares with a return of about 1.7% over the past day, in contrast with weaker performance over the past month and the past three months. See our latest analysis for Patria Investments. Zooming out, the share price tells a mixed story, with a 1 day share price return of 1.67% against a weaker 30 day move and a 30 day share price return of 13.29% decline, while the...

If you are wondering whether Getty Realty at around US$32 per share offers value or is priced for perfection, the starting point is understanding what the current market price actually reflects. The stock has delivered a 16.8% return year to date and 13.4% over the past year, even though the last month showed a 0.4% slip and the most recent week a 3.7% decline, which can change how the market views both its potential and its risks. Recent attention on Getty Realty has focused on its position...

Wondering whether WeRide at around US$7.53 is a bargain or a value trap? This article walks through what the current price may be implying about the stock. The share price has moved sharply in the very short term, with a 20.3% return over the last 7 days and 2.6% over the last 30 days, despite a 19.8% decline year to date and a 49.6% decline over the past year. Recent news around WeRide has focused on its position in the autonomous driving and auto technology space, alongside broader...